hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Company survey response

Novartis

Member of UN Global Compact

Headquarters in Switzerland

Novartis website

🔎 Run a search for “Novartis”

Get RSS feed of these results

All stories

Lawsuit
26 March 2014

Novartis lawsuit (re India patent law & access to medicine)(new)

Author: Business & Human Rights Resource Centre

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

Read more

Story
25 March 2014

Novartis lawsuit (re India patent law & access to medicine)

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

See full story

Article
19 February 2014

Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines - company responses/non-responses

Author: Business & Human Rights Resource Centre

In January 2014, the Innovative Pharmaceutical Association of South Africa (IPASA) was accused of planning and funding an advocacy campaign on behalf of its member companies. The campaign allegedly sought to oppose South Africa’s efforts to introduce...

Read more

Company response
19 February 2014

Response by Novartis: Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines

Read full response

Story
17 February 2014
+ Español - Hide
Article
17 February 2014
+ Español - Hide

Author: Fundación Ideas para la Paz (Colombia)

En 2011…un grupo de empresas suizas que operan en Colombia se reunieron con el fin de formalizar su compromiso respecto a la integración a su gestión, de los Derechos Humanos (DDHH) y el Derecho Internacional Humanitario (DIH)…[En 2012] las empresas...

Read more

Article
6 January 2014

To patent or not to patent? the case of Novartis’ cancer drug Glivec in India

Author: Ravinder Gabble & Jillian Clare Kohler, in Global Health (USA)

Glivec...produced by the pharmaceutical company Novartis, is prescribed [to treat]...one of the most common blood cancers in eastern countries...[T]he Supreme Court of India gave its final decision...rejecting the appeal of the Swiss...drug...

Read more

Article
1 January 2014

[PDF] Corporate influence in the Post-2015 process

Author: Lou Pingeot, Global Policy Forum

[T]his working paper examines the role and influence of business actors in the process towards the Post-2015 agenda of the UN, with particular attention to the influence of large transnational corporations. The business sector certainly has an...

Read more

Article
20 December 2013

Study: 51 of 100 Top Companies Emitting Unsustainable Levels of CO2

Author: Mary Mazzoni, TriplePundit

Climate Counts and the Center for Sustainable Organizations just released what they call the “world’s first” science-based company rankings,...[assessing] the emissions performance of 100 companies from 2005 to 2012 within the context of climate...

Read more

Article
9 December 2013

Best Places to Work 2014 [USA]

Author: Human Rights Campaign

This year, an historic 304 major businesses…scored 100 percent on HRC’s Corporate Equality Index and the coveted distinction of “Best Places to Work for LGBT Equality.” These companies adopted a full framework of LGBT inclusion in the workplace,...

Read more